C

Cidara Therapeutics

D
CDTX
USD
-0.065
(-0.4909%)
Market Closed
473.00
Volume
-24.49
EPS
-
Div Yield
-0.535569
P/E
92,728,825.18
Market Cap
Today
-0.4909%
1 Week
2.569%
1 Month
19.773%
6 Months
-2.768%
12 Months
-18.035%
Year To Date
-15.965%
All Time
15.570%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
MRK
MRK
-0.89
(-0.872%)
USD
PFE
PFE
0.135
(0.4941%)
USD
GSK
GSK
0.76
(2.117%)
USD
BMY
BMY
-0.57
(-1.0313%)
USD
AZN
AZN
0.335
(0.5207%)
USD
LLY
LLY
-2.235
(-0.2794%)
USD
REGN
REGN
8.505
(1.0417%)
USD
VRTX
VRTX
9.22
(1.869%)
USD
NVO
NVO
2.27
(2.1547%)
USD
NVS
NVS
0.23
(0.2153%)
USD

Title:
Cidara Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak(R) platform targeting oncologic, viral and autoimmune diseases.
Do you need help or have a question?
Contact Us